Hepatopancreatoduodenectomy for the treatment of extrahepatic cholangiocarcinoma  

作　　者：Alberto Porcu Giulia Deiana Claudio F Feo Chiara Ninniri Davide Turilli Lorena Tanda Alessandro Fancellu 

机构地区：[1]Department of Clinical,Surgical and Experimental Sciences,Unit of General Surgery 2–Clinica Chirurgica,University of Sassari,Sassari,Italy [2]Unit of Radiological Sciences,AOU Sassari,Sassari,Italy [3]Faculty of Medicine and Surgery,University of Sassari,Sassari,Italy

出　　处：《Hepatobiliary & Pancreatic Diseases International》2023年第4期430-433,共4页国际肝胆胰疾病杂志（英文版）

基　　金：supported by the FAR19 grant of the University of Sassari,Italy.

摘　　要：To the Editor:Extrahepatic cholangiocarcinoma(ECC)is an uncommon neoplasm associated with a poor prognosis[1-3].Surgical resection represents the only curative approach,since systemic treatments have scarce efficacy in achieving disease control.However,only 10%-40%of patients with ECC are resectable at diagnosis[1].Ma-jor hepatectomy and portal lymphadenectomy are usually required for hilar ECC,while pancreatoduodenectomy is the standard operation for distal ECC[3-5].However,ECC may spread horizon-tally along the biliary tree,causing tumor involvement of the entire extrahepatic biliary system.In these circumstances,hep-atopancreatoduodenectomy(HPD)has been proposed as a pro-cedure with curative intent[2,6,7].

关 键 词：PANCREATODUODENECTOMY EXTRAHEPATIC INVOLVEMENT 

分 类 号：R735.8[医药卫生—肿瘤]